Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000235519 | SCV000293316 | pathogenic | not provided | 2015-11-19 | criteria provided, single submitter | clinical testing | The c.584+2 T>G splice site variant in the MPZ gene has been previously reported, using alternative nomeclature of c.614+2 T>G, in association with CMT1B, and RT-PCR studies on dermal skin biopsies confirmed that c.584+2 T>G is associated with abnormal splicing (Sabet et al., 2006). This pathogenic variant destroys the canonical splice donor site in intron 4, and is expected to cause abnormal gene splicing. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. |
OMIM | RCV000015261 | SCV000035520 | pathogenic | Charcot-Marie-Tooth disease type 1B | 2006-10-10 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium | RCV000790116 | SCV000929506 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |